ohOn a Sunday evening in late June, the Danish beach town of Tisvilde was quiet after a busy weekend. In the little blue shack that houses Hansen’s Ice Cream Parlour, families were reserving their last sips of organic vanilla ice cream. Sun-tanned teenagers with sandy toes and cat-eye sunglasses were strolling down the sidewalk back into town. Quaint, laid-back and breezy, Tisvilde has been a magnet for Copenhagen’s creative class for decades. It’s reminiscent of Long Island’s East End in the ’70s, before billionaires arrived and high-end fashion boutiques transformed Bergdorf-sur-Mer’s picturesque main street.
But that may be changing. Tisvilde, known as the Danish Riviera, and its neighboring towns are already seeing signs of an economic boom thanks in part to Ozempic. Over the past two years, Novo Nordisk, maker of the weight-loss drug (and half the world’s insulin supply), has transformed Denmark’s economy, and claims to boost GDP by 1.8% in 2023.
